Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicity

Project description

Personalised reproductive health support for young cancer survivors

Adolescents and young adults (AYAs) who are cancer survivors face challenges related to their reproductive health, sexuality, and quality of life. The EU-funded PredictAYA project will improve our understanding of the long-term effects of cancer treatment on AYAs aged 15-39. The project will use data from population registries, genomic biobanks, and clinical cohorts. It will focus on capturing patients’ perspectives regarding their care preferences and the psychosocial impacts of treatment. It will develop biomarkers to identify individuals at high risk of organ toxicities, facilitating personalised screening and counselling. Additionally, the study will investigate reproductive toxicity, using precision medicine to explore genetic factors that contribute to treatment-induced toxicity. This initiative is part of the Cancer Mission.

Objective

PredictAYA is a multidisciplinary effort to fully address and improve the understanding of late effects in AYAs 15-39 years treated for cancer, by building on data from existing populations-based registers, large genomic biobanks and newly established clinical AYA cohorts. Importantly, the patient perspective will be captured in our clinical cohorts and patients’ care preferences and needs including the psychosocial impact of cancer treatment on reproductive health, sexuality and quality of life in AYAs. By cooperation between clinicians, researchers, psychologists, oncology nurses and with patient involvement, the study will use a participatory research approach and develop in co-creation with representative AYAs with cancer. This action is part of the Cancer Mission cluster of projects on “Quality of life (AYA).

Our long-term goal is to develop a panel of validated biomarkers to identify individuals at high-risk of organ toxicities, aiming at clinical implementation and future individualized screening and counselling. Our main focus is on reproductive toxicity and through innovative precision medicine and pharmacogenetics, we will identify genetic biomarkers explanatory for interindividual variation in treatment induced toxicity among AYAs. A model on constitutional genetic risk for reproductive organ toxicity will be evaluated in clinical cohorts across Europe. Future precision-medicine applications and clinical implementation are envisaged as potential benefit of our proposal.

Additional research questions include the prevalence, severity and timing of gonadal toxicity for different cancer treatments in both sexes, the timing and risks of pregnancy, the risk of accelerated aging, the health of the children born to AYAs. The safety and efficacy of fertility preservation methods will be investigated in detail. Our methodology will also allow us to investigate additional phenotypes and find associations among reproductive, endocrine, cardiac and neurologic toxicity, risk factors including social and health determinants and comorbidity patterns.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-RIA - HORIZON Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MISS-2024-CANCER-01

See all projects funded under this call

Coordinator

KAROLINSKA INSTITUTET
Net EU contribution
€ 1 140 308,75
Address
NOBELS VAG 5
171 77 STOCKHOLM
Sweden
Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 140 308,75

Participants (17)

Partners (1)